Aisling Capital launching fourth, $400M life sciences fund
The private equity firm's fourth fund has a hard cap of $500 million. It has a vast portfolio in the life sciences, including Cidara Therapeutics, T2 Biosystems and Seragon Pharmaceuticals.
The private equity firm's fourth fund has a hard cap of $500 million. It has a vast portfolio in the life sciences, including Cidara Therapeutics, T2 Biosystems and Seragon Pharmaceuticals.
Market research firm CB Insights just put out a nifty infographic that denotes how 69 different life sciences startups fit within the body.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Last year, Rock Health took the first look at gender diversity on the stages of a dozen high-profile healthcare conferences. We knew from experience that women were largely confined to the attendee list at these events, and we were appalled when our research confirmed that only a quarter of speakers in 2013 were women. We […]
“MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences” An Indiana life sciences company looks at metabolites as snapshots to diagnose and monitor cancer. The idea is that cancerous cells have distinct differences in metabolism than healthy cells. Matrix-Bio, a startup with corporate […]
Cate Blanchett – Acceptance Speech – Oscars 2014 by IdolxMuzic As Cate Blanchett so aptly explained in her stunning Oscar acceptance speech: Woman-centered does not equal “niche experience.” Dr. Anula Jayasuriya pointed out how Blanchett’s speech rings true to much of healthcare. “People call women’s health a niche, and it’s hard for me to parse […]
Since 2005 startup accelerators have provided cohorts of startups with mentoring, pitch practice and product focus. However, accelerator Demo Days are a combination of graduation ceremony and pitch contest, with the uncomfortable feel of a swimsuit competition. Other than “I’ll know it when I see it,” there’s no formal way for an investor attending Demo […]